Overview
Pure autonomic failure (PAF), also known as Bradbury-Eggleston syndrome or idiopathic orthostatic hypotension, is a rare neurodegenerative disorder of the autonomic nervous system. It is classified as a synucleinopathy, characterized by abnormal accumulation of alpha-synuclein in peripheral autonomic neurons. PAF primarily affects the autonomic (involuntary) nervous system, which controls functions such as blood pressure regulation, heart rate, bladder function, sweating, and gastrointestinal motility. Unlike other synucleinopathies such as multiple system atrophy or Parkinson disease with autonomic failure, PAF does not involve significant central nervous system degeneration, at least in its early stages. The hallmark symptom of PAF is severe orthostatic hypotension — a dramatic drop in blood pressure upon standing — which leads to dizziness, lightheadedness, blurred vision, and fainting (syncope). Other common symptoms include urinary dysfunction (urinary frequency, urgency, or retention), constipation, reduced sweating (anhidrosis or hypohidrosis), erectile dysfunction in men, and supine hypertension (elevated blood pressure when lying down). Symptoms typically develop insidiously in middle to late adulthood. Notably, some patients with PAF may eventually convert (phenoconvert) to other synucleinopathies, including Parkinson disease, dementia with Lewy bodies, or multiple system atrophy, making long-term follow-up essential. There is currently no cure or disease-modifying therapy for PAF. Treatment is symptomatic and focuses primarily on managing orthostatic hypotension and other autonomic symptoms. Non-pharmacological measures include increased fluid and salt intake, wearing compression garments, and avoiding sudden postural changes. Pharmacological options include midodrine (a vasopressor), droxidopa (a norepinephrine precursor approved for neurogenic orthostatic hypotension), and fludrocortisone (a mineralocorticoid to expand blood volume). Management of supine hypertension, which often coexists with orthostatic hypotension, requires careful balancing of treatments. Patients benefit from multidisciplinary care involving neurologists, cardiologists, and urologists.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsLUMA Vision Ltd.
Martini Hospital Groningen — PHASE4
Assistance Publique - Hôpitaux de Paris — NA
Liverpool John Moores University — NA
Boston Scientific Corporation — NA
CathVision ApS
Northwestern University — NA
Tomsk National Research Medical Center of the Russian Academy of Sciences — PHASE4
Pulse Biosciences, Inc. — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
2 availableNORTHERA
indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caus…
indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (pure autonomic failure)
Amatine
Treatment of symptomatic orthostatic hypotension.
Rare Disease Specialist
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Pure autonomic failure.
Community
No community posts yet. Be the first to share your experience with Pure autonomic failure.
Start the conversation →Latest news about Pure autonomic failure
Disease timeline:
New recruiting trial: EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: The Impact of Expandable Cryoballoon on Autonomic Control of the Heart
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: STOP AF First Post-Approval Study
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: Evaluation of the Impact of Pulsed Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in Patients With Paroxysmal Atrial Fibrillation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation
A new clinical trial is recruiting patients for Pure autonomic failure
New recruiting trial: LA Function After PFA in Paroxysmal AF
A new clinical trial is recruiting patients for Pure autonomic failure
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pure autonomic failure
What is Pure autonomic failure?
Pure autonomic failure (PAF), also known as Bradbury-Eggleston syndrome or idiopathic orthostatic hypotension, is a rare neurodegenerative disorder of the autonomic nervous system. It is classified as a synucleinopathy, characterized by abnormal accumulation of alpha-synuclein in peripheral autonomic neurons. PAF primarily affects the autonomic (involuntary) nervous system, which controls functions such as blood pressure regulation, heart rate, bladder function, sweating, and gastrointestinal motility. Unlike other synucleinopathies such as multiple system atrophy or Parkinson disease with aut
How is Pure autonomic failure inherited?
Pure autonomic failure follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pure autonomic failure typically begin?
Typical onset of Pure autonomic failure is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Pure autonomic failure?
Yes — 1 recruiting clinical trial is currently listed for Pure autonomic failure on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Pure autonomic failure?
25 specialists and care centers treating Pure autonomic failure are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Pure autonomic failure?
1 patient support program are currently tracked on UniteRare for Pure autonomic failure. See the treatments and support programs sections for copay assistance, eligibility, and contact details.